Literature DB >> 3619430

In vitro activity of systemic antifungal agents against Malassezia furfur.

M J Marcon, D E Durrell, D A Powell, W J Buesching.   

Abstract

The activity of four antifungal agents against 15 systemic (blood and vascular catheter) and 10 superficial (skin) Malassezia furfur isolates was evaluated. MIC ranges were similar for the two groups of organisms: amphotericin B, 0.3 to 2.5 micrograms/ml; flucytosine, greater than 100 micrograms/ml; miconazole, 0.4 to 1.5 micrograms/ml; and ketoconazole, 0.025 to 0.4 micrograms/ml.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3619430      PMCID： PMC284220          DOI： 10.1128/AAC.31.6.951

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  Malasezzia furfur sepsis in neonates.

Authors:  W M Dankner; S A Spector
Journal:  J Pediatr       Date:  1985-10       Impact factor: 4.406

2.  The activity in vitro of five different antimycotics against Pityrosporum orbiculare.

Authors:  J Faergemann; S Bernander
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437

3.  A semiquantitative culture method for identifying intravenous-catheter-related infection.

Authors:  D G Maki; C E Weise; H W Sarafin
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

4.  Systemic Malassezia furfur infections in patients receiving intralipid therapy.

Authors:  R W Redline; S S Redline; B Boxerbaum; B B Dahms
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

5.  In vitro and in vivo activities of ketoconazole and itraconazole against Pityrosporum orbiculare.

Authors:  J Faergemann
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

6.  Broviac catheter-related Malassezia furfur sepsis in five infants receiving intravenous fat emulsions.

Authors:  D A Powell; J Aungst; S Snedden; N Hansen; M Brady
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

7.  Methods for optimal recovery of Malassezia furfur from blood culture.

Authors:  M J Marcon; D A Powell; D E Durrell
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

8.  Catheter-related infection in infants due to an unusual lipophilic yeast--Malassezia furfur.

Authors:  J G Long; H L Keyserling
Journal:  Pediatrics       Date:  1985-12       Impact factor: 7.124
  8 in total
  7 in total

1.  In vitro activities of ketoconazole, econazole, miconazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species.

Authors:  K A Hammer; C F Carson; T V Riley
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 2.  Human infections due to Malassezia spp.

Authors:  M J Marcon; D A Powell
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

Review 3.  Amphotericin B: current understanding of mechanisms of action.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

4.  A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.

Authors:  S Rincón; M C Cepero de García; A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 5.  The Malassezia genus in skin and systemic diseases.

Authors:  Georgios Gaitanis; Prokopios Magiatis; Markus Hantschke; Ioannis D Bassukas; Aristea Velegraki
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

6.  In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.

Authors:  Margarita Garau; Manolo Pereiro; Amalia del Palacio
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

7.  Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest.

Authors:  Aristea Velegraki; Evangelos C Alexopoulos; Stavroula Kritikou; George Gaitanis
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.